Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 4031-4032

  Tran, T A ^a,b   Pariente, D ^a,b   Lecron, J C ^c,d   Delwail, A ^c,d   Taoufik, Y ^a,b   Meinzer, U ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; INTERLEUKIN 1; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; VINBLASTINE;

ARTICLE; BONE BIOPSY; BONE RADIOGRAPHY; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG TARGETING; ERDHEIM CHESTER DISEASE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD;

ANTIRHEUMATIC AGENTS; CHILD; ERDHEIM-CHESTER DISEASE; FEMALE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECEPTORS, INTERLEUKIN-1; TREATMENT OUTCOME;

EID: 82455163723     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30638     Document Type: Article

References (9)

1. Veyssier-Belot C, Cacoub P, Casparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease. Clinical and radiological characteristics of 59 cases. Medicine (Baltimore) 1996; 75: 157-69. (Pubitemid 26159212)
2. Myra C, Sloper L, Tighe PJ, McIntosh RS, Stevens SE, Gregson RH, et al. Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004; 88: 844-7. (Pubitemid 38725610)
3. Boissel N, Wechsler B, Leblond V,. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001; 135: 844-5. (Pubitemid 33051276)
4. Sheidow TG, Nicolle DA, Heathcote JG,. Erdheim-Chester disease: two cases of orbital involvement. Eye 2000; 14: 606-12.
5. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R,. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α. Blood 2005; 106: 2992-4. (Pubitemid 41565890)
6. Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, Grenier PA, et al. Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum 2006; 54: 3330-6. (Pubitemid 44622105)
7. Perlat A, Decaux O, Sebillot M, Grosbois B, Desfourneaux V, Meadeb J,. Erdheim-Chester disease with predominant mesenteric localization: lack of efficacy of interferon α. Joint Bone Spine 2009; 76: 315-7.
8. Tran TA, Fabre M, Pariente D, Craiu I, Haroche J, Charlotte F, et al. Erdheim-Chester disease in childhood: a challenging diagnosis and treatment. J Pediatr Hematol Oncol 2009; 31: 782-6.
9. Aouba A, Georgin-Lavialle S, Pagnoux C, Martin Silva N, Renand A, Galateau-Salle F, et al. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010; 116: 4070-6.